ライフサイエンスコーパス: drug overdose

1 rug overdose and 1323 (1.0%) died of a fatal drug overdose.

2 pproximately 0.2% had a pregnancy-associated drug overdose.

3 s in HIV-positive persons were due to occult drug overdose.

4 ehealth services, receipt of MOUD, and fatal drug overdose.

5 ceived grafts from donors who died of anoxic drug overdose.

6 per 1000 person-years, with 51.8% dying from drug overdose.

7 , Clinical Modification codes for a nonfatal drug overdose.

8 rbidity and mortality, particularly owing to drug overdose.

9 ie sex differences in human vulnerability to drug overdose.

10 escription in the 12 months after a nonfatal drug overdose.

11 019 in years of life lost from unintentional drug overdose.

12 treat cancer, allergy, and potentially even drug overdose.

13 t common drugs associated with unintentional drug overdose.

14 e design of next-generation therapeutics for drug overdose.

15 lipid reversal of cardiac toxicity caused by drug overdose.

16 her disorders such as acute pancreatitis and drug overdose.

17 ocaine addiction, and for emergency cases of drug overdose.

18 total of 1727 individuals (24.2%) died of a drug overdose.

19 on in the 12 months after the index nonfatal drug overdose.

20 hildren lost a parent aged 18 to 64 years to drug overdose.

21 se in the 12 months after the index nonfatal drug overdose.

22 s earlier and more frequently of suicide and drug overdose.

23 Opioids were involved in 72.2% of fatal drug overdoses.

24 ces as well as subsequent nonfatal and fatal drug overdoses.

25 The US faces an unprecedented surge in fatal drug overdoses.

26 e world, it is also a leading cause of toxic drug overdoses.

27 een due to unintentional deaths from illicit drug overdoses.

28 (0.014 to 0.58)), but no change was seen for drug overdose (-0.12 (-0.41 to 0.18)).

29 iratory (10%), digestive diseases (10%), and drug overdose (10%).

30 arkedly elevated relative risk of death from drug overdose (129; 95% CI, 89 to 186).

31 t postmortem examination without evidence of drug overdose; 2 of these chemicals have known associati

32 In the 12 months after their index nonfatal drug overdose, 23 815 beneficiaries (17.4%) experienced

33 er players (2 neurodegenerative disorders, 2 drug overdoses, 3 suicides, and 4 vehicular crashes amon

34 r primary graft failure, 58.6% and 54.0% for drug overdose, 53.2% and 45.3% for dilated cardiomyopath

35 t study of people experiencing homelessness, drug overdose accounted for 1 in 4 deaths, with syntheti

36 creasing across all racial groups, caused by drug overdoses, alcohol abuse, suicides, and a diverse l

37 nal), and six etiologies (infection, trauma, drug overdose, allergy/immunology, diabetes, miscellaneo

38 se during pregnancy and the risk of nonfatal drug overdose among pregnant persons with opioid use dis

39 suicide, alcohol-related liver disease, and drug overdose among young adults has become a critical p

40 s, were associated with an increased risk of drug overdose among young people during the following 6-

41 In response to reports of unintentional drug overdoses among children given over-the-counter (OT

42 Fatal drug overdoses among pregnant and postpartum individuals

43 ) experienced at least 1 subsequent nonfatal drug overdose and 1323 (1.0%) died of a fatal drug overd

44 and doctor shopping, MAT, and prevalence of drug overdose and opioid use disorder.

45 nts of organs from donors who died of anoxic drug overdose and recipients of organs from donors who d

46 died in the bictegravir group (recreational drug overdose and suicide, neither of which was treatmen

47 In this cohort study of fatal drug overdose and the spread of fentanyl through Oregon'

48 stem this problem should prioritize averting drug overdoses and firearm violence, especially among st

49 Increasing mortality from suicide, drug overdose, and alcohol-related liver disease (collec

50 ed risk ratios (RRs) of deaths from suicide, drug overdose, and alcoholic liver disease.

51 e to opioids results in analgesic tolerance, drug overdose, and death.

52 used to identify cases of homicide, suicide, drug overdose, and deaths involving firearms occurring i

53 ychiatric complications (suicide, accidental drug overdose, and suicide attempt).

54 including 837 homicides, 579 suicides, 2083 drug overdoses, and 851 that involved firearms.

55 cial treatment initiation, medically treated drug overdoses, and all-cause acute care visits after di

56 ly lower adjusted odds ratio (aOR) for fatal drug overdose (aOR, 0.67; 95% CI, 0.48-0.92) as was rece

57 was not associated with lower odds for fatal drug overdose (aOR, 1.16; 95% CI, 0.41-3.26).

58 services to individuals at highest risk for drug overdose are paramount to addressing the drug overd

59 s was associated with reduced risk for fatal drug overdose, as was receipt of MOUD from opioid treatm

60 The crude incidence of drug overdose at 6 months was 0.9% for benzodiazepine in

61 ographic disparities in pregnancy-associated drug overdose between 2010 and 2019.

62 an age, 42 years [IQR, 33-54 years]) died of drug overdose between January 2015 and October 2024.

63 or interdiction efforts and the diagnosis of drug overdose, but existing analytical methods lack broa

64 ng causes of death among former inmates were drug overdose, cardiovascular disease, homicide, and sui

65 th from unintentional injuries (particularly drug overdoses), chronic liver disease, diabetes, and he

66 APACHE II risk of death, using the original drug overdose coefficient, was poorly calibrated.

67 The drug overdose crisis is a continuing public health probl

68 The US is experiencing a protracted drug overdose crisis primarily associated with exposure

69 The United States continues to suffer a drug overdose crisis that has resulted in over 100 000 d

70 rug overdose are paramount to addressing the drug overdose crisis.

71 rrent opioid epidemic, utilization of anoxic drug overdose DCD donor grafts does not increase the ris

72 Despite high rates of drug overdose death among people experiencing homelessne

73 Adjusted drug overdose death hazards (and 95% CIs) were also eval

74 bioavailability and is the leading cause of drug overdose death in the U.S.

75 h care workers, annual standardized rates of drug overdose death per 100 000 persons ranged from 2.3

76 Mortality assessed by drug overdose death rates involving prescription opioids

77 ply escalating racial/ethnic inequalities in drug overdose death rates.

78 A persistently high US drug overdose death toll and increasing health care use

79 Drug overdose death totals were estimated for every 6-mo

80 care workers, the adjusted hazards of total drug overdose death were significantly increased for soc

81 Parental drug overdose death, stratified by age group, sex, and r

82 e support workers were at increased risk for drug overdose death, suggesting the need to identify and

83 e use is the second leading cause of illicit drug overdose death.

84 Similar decreases were observed in RI in drug overdose deaths (-172 per 100 000 person-years per

85 Drug overdose deaths (DODs) surged with the advent of fe

86 Drug overdose deaths (largely attributable to opioid mis

87 The primary outcome was the number of drug overdose deaths among adults (aged 18 years or olde

88 This study assesses trends in drug overdose deaths among US adolescents aged 14 to 18

89 overdose deaths, accounting for 2.2% of all drug overdose deaths and 2.6% of opioid-involved overdos

90 amined the association of those reforms with drug overdose deaths and other injury fatalities.

91 The rising number of drug overdose deaths and the changing legal status of ma

92 Drug overdose deaths and the types of drugs involved in

93 dose diagnosis, the prescription of MAT, and drug overdose deaths before and after implementation of

94 entifies a significant percentage of illicit drug overdose deaths but obscures the specific drug(s) i

95 Despite an unprecedented increase in drug overdose deaths in the United States, the risks fac

96 y 2020 and December 2021, there were 159 872 drug overdose deaths in the United States.

97 pioid crisis, with the third highest rate of drug overdose deaths in the United States.

98 There are more drug overdose deaths in the Untied States than motor veh

99 Drug overdose deaths in the US are currently the highest

100 tics System to compare forecasted numbers of drug overdose deaths in the US in the latter 43 weeks of

101 opioid crisis with the third highest rate of drug overdose deaths in the US.

102 cs System Mortality to evaluate trends in US drug overdose deaths involving opioids certified as unin

103 ited States, for example, opioids cause more drug overdose deaths than any other substance.

104 Age- and sex-standardized drug overdose deaths were determined for 6 health care w

105 By December 2013, drug overdose deaths were down 17% (95% credible interva

106 Drug overdose deaths were identified using International

107 Benzodiazepines are commonly identified in drug overdose deaths worldwide.

108 n working-age adults given adverse trends in drug overdose deaths, other external causes of death, an

109 For other drug overdose deaths, the mean number of deaths per day

110 oid prescribing reform substantially reduced drug overdose deaths.

111 Opioids were involved in 91.0% of all drug overdose deaths.

112 Of the drug overdose decedents, 456 were female (26.4%), 194 we

113 This study aimed to compare trends in use of drug overdose (DO) donors in adult versus pediatric live

114 This study aimed to compare trends in use of drug overdose (DO) donors in adult vs. pediatric liver t

115 ents, 243 985 patients (32.8%) had suspected drug overdose documentation as either the primary or sec

116 5 years was similar for recipients of anoxic drug overdose donor grafts and recipients of other graft

117 Grafts from anoxic drug overdose donors were less frequently used compared

118 nalties for drug possession may reduce fatal drug overdoses due to reduced incarceration and increase

119 ximately 0.07% of our study sample died of a drug overdose during follow-up.

120 eral emerging characteristics of deaths from drug overdose during the first year of the COVID-19 pand

121 from homicide, suicide, transportation, and drug overdoses during the COVID-19 pandemic.

122 Reversal of the drug overdose epidemic will be beneficial, but insuffici

123 are increasing amidst the ongoing opioid and drug overdose epidemic.

124 urveillance of pregnancy-associated nonfatal drug overdose events and clinical interventions to reduc

125 n this cross-sectional study of survivors of drug overdose, fewer than half of recent overdose events

126 Drug overdoses from opioids and stimulants are a major c

127 Drug overdoses have become the number 1 cause of mortali

128 Since 2020, over 100,000 fatal drug overdoses have been reported annually, and 75% of t

129 due to suicide, alcohol-related disease, or drug overdose, have doubled in the past decade, with par

130 ze trends in death and excess mortality from drug overdoses, homicides, unintentional injuries, motor

131 .0] years) who experienced an index nonfatal drug overdose in 2020.

132 cope of populations susceptible to synthetic drug overdose in North America (eg, among adolescents ex

133 sociated with reduced adjusted odds of fatal drug overdose in the 12 months after the index nonfatal

134 aths of otherwise healthy individuals due to drug overdose in the United States has major implication

135 estimated 321 566 children lost a parent to drug overdose in the US from 2011 to 2021, with signific

136 number of children who have lost a parent to drug overdose in the US.

137 s from home residences to locations of fatal drug overdoses in Cook County, Illinois, from August 1,

138 Provisional estimates of fatal drug overdoses in the US are lagging by 6 months.

139 Trends in and characteristics of nonfatal drug overdoses in this population, however, remain unkno

140 ) visits for psychiatric disorders (PDs) and drug overdoses increased.

141 , and OUD-related clinical events (including drug overdose, inpatient detoxification and rehabilitati

142 Drug overdose is an important safety consideration when

143 ts were quarterly state-level mortality from drug overdoses, known indicators for prescription opioid

144 9 599 adults aged 18 to 64 years died from a drug overdose (mean [SD] age, 41.7 [12.0] years; 430 050

145 ontinuation from long term opioid treatment, drug overdose, mental health crises, admissions to hospi

146 Monthly, national drug overdose mortality counts were obtained from the Ce

147 1999 to 2017, we show that the age-specific drug overdose mortality curve for each birth-year cohort

148 This cross-sectional study of drug overdose mortality data and insurance claims data f

149 ARTICIPANTS: This cross-sectional study used drug overdose mortality data from 50 states obtained fro

150 nal study describes the nationwide trends in drug overdose mortality during the COVID-19 pandemic by

151 o Department of Health to evaluate trends in drug overdose mortality in that state by type of drug an

152 The age- and sex-standardized drug overdose mortality rate in the BHCHP cohort was 278

153 experienced the nation's largest increase in drug overdose mortality rates during 1999-2004.

154 oss-sectional study evaluates the changes in drug overdose mortality rates for Kentucky residents bet

155 ectional study evaluates trends in increased drug overdose mortality rates in the US by race and ethn

156 eople experiencing homelessness, patterns in drug overdose mortality, including the types of drugs im

157 housing, increased homelessness, and record drug overdose mortality.

158 = 17 [14.5%]), cancer (n = 17 [14.5%]), and drug overdose (n = 14 [12.0%]).

159 rates included acute myocardial infarction, drug overdose, nonoperative head trauma, and nonoperativ

160 Drug overdose (OD) is a public health challenge and an i

161 erdose crisis account for the full burden of drug overdose on families and children, including addres

162 , metabolic disorders (three), trauma (two), drug overdose (one), and unknown reasons (one).

163 own association with reduced risk of a fatal drug overdose, only a small percentage of Medicare benef

164 hospitalizations, opioid prescriptions, and drug overdose (opioid or non-opioid).

165 sks (aRRs) were generated for the outcome of drug overdose or all-cause death within 1 year post part

166 The overall risk of postpartum drug overdose or death was 1.5%.

167 ith increasing degrees of risk of postpartum drug overdose or death.

168 Emergency or hospital encounters for (1) drug overdose or withdrawal and (2) mental health crisis

169 Emergency or hospital encounters for drug overdose or withdrawal and mental health crisis (de

170 h substance use disorders, chief concerns of drug overdose or withdrawal, and/or positive verbal scre

171 This study focused on unintentional drug overdoses or drug overdoses with undetermined inten

172 well as longer-term associations with fatal drug overdose overall and across racial and ethnic group

173 ldren losing a parent aged 18 to 64 years to drug overdose, overall and by age, sex, and race and eth

174 unity-dwelling children who lost a parent to drug overdose per 100 000 children increased from 27.0 p

175 e rate difference post Blake was 0.112 fatal drug overdoses per 100 000 state population.

176 difference post Measure 110 was 0.268 fatal drug overdoses per 100 000 state population.

177 iac arrest outside of a hospital may include drug overdose, pulmonary embolism, subarachnoid hemorrha

178 re changes in drug possession laws and fatal drug overdose rates in Oregon and Washington in the post

179 The primary outcome assessed was fatal drug overdose rates per half-year.

180 ossession in Oregon and Washington and fatal drug overdose rates.

181 Roughly half of the drug overdose-related deaths in the United States are re

182 tion filing rates, but their impact on fatal drug overdoses remains unexplored.

183 study used data from the State Unintentional Drug Overdose Reporting System (SUDORS) to assess overdo

184 ated mortality due to homicide, suicide, and drug overdose, state-level incidence has previously not

185 n the years when deaths rose rapidly through drug overdoses, suicides, and alcoholic liver disease an

186 rease in mortality from specific causes (eg, drug overdoses, suicides, organ system diseases) among y

187 l protections when a bystander to a possible drug overdose summons help.

188 ulting in dependency and a recent upsurge in drug overdoses that have contributed to a significant de

189 the early pandemic period with unintentional drug overdoses, the usual leading cause of death in youn

190 eclinical evidence of clinical potential for drug overdose treatment without a question mark on the t

191 Mortality from all causes, unintentional drug overdoses, unintentional opioid and polydrug overdo

192 mortality ratios for homicide, suicide, and drug overdose varied across the US.

193 Drug overdose was a leading cause of death across age, g

194 In adjusted analyses, an increased risk of drug overdose was associated with benzodiazepines vs com

195 0 000 live births), and pregnancy-associated drug overdose was highest in Delaware (36.03 deaths per

196 d sudden cardiac deaths, death due to occult drug overdose was more common in persons with known HIV

197 The percentage of deaths due to a fatal drug overdose was similar in the prepandemic (4.8%) and

198 In 2021, drug overdose was the leading cause of orphanhood among

199 The rate of fatal drug overdoses was higher in the pandemic cohort than in

200 A total of 470 adults who died of drug overdose were included in the analysis (353 men [75

201 ving the increase in external mortality, but drug overdoses were already increasing for a full year b

202 Incident diagnosed drug overdoses were identified from inpatient and emerge

203 y focused on unintentional drug overdoses or drug overdoses with undetermined intent involving the mo

204 The leading cause of death among PEH is drug overdose, with opioids accounting for the majority